Kintara Therapeutics Quote - KTRA

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.3102

Bid

0.3101

Offer

0.3102

Volume

47,248,824

0.19 Day's Range 0.2997

0.081 52 Week Range 5.60

Market Cap

10.931M

Previous Close

0.216

Open

0.2051

Last Trade

500

0.3102

(formt)

Last Trade Time

Financial Volume

US$ 11,893,446

VWAP

0.251719

Average Volume (3m)

15,564,965

Shares Outstanding

39,037,899

Dividend Yield

PE Ratio

-0.73

Earnings Per Share (EPS)

-0.38

Revenue

Net Profit

-15.02M

Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and ... Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and REM-001 for CMBC. VAL-083 is a small-molecule chemotherapeutic with a novel mechanism of action that has demonstrated clinical activity against a range of cancers, including the central nervous system, ovarian, and other solid tumors. The company is also advancing its proprietary late stage photodynamic therapy (PDT) platform that holds promise as a localized cutaneous or visceral tumor treatment as well as in other potential indications. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.kintara.com

Headquarters

Reno, Nevada, USA

Founded

1970

Kintara Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KTRA. The last closing price for Kintara Therapeutics was US$0.22. Over the last year, Kintara Therapeutics shares have traded in a share price range of US$ 0.081 to US$ 5.60.

Kintara Therapeutics currently has 39,037,899 shares in issue. The market capitalisation of Kintara Therapeutics is US$10.93 million. Kintara Therapeutics has a price to earnings ratio (PE ratio) of -0.73.

TuHURA Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC)

TuHURA Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell...

Period †	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.1062	52.0588235294	0.204	0.2997	0.1703	8064409	0.20853515	CS
4	0.1217	64.5623342175	0.1885	0.417	0.1508	17779645	0.26017817	CS
12	0.2025	188.022284123	0.1077	0.417	0.0925	15564965	0.19118231	CS
26	0.1202	63.2631578947	0.19	0.417	0.081	13746638	0.16100708	CS
52	-3.3598	-91.5476839237	3.67	5.6	0.081	7015052	0.19125137	CS
156	-97.6898	-99.6834693878	98	142.5	0.081	3335448	6.89769278	CS
260	-60.1898	-99.4872727273	60.5	167.5	0.081	2775371	12.02392119	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
K2FK2fly Limited	AUD 0.1825 (82.50%)	2.11M
ME1OEMelodiol Global Health Ltd	AUD 0.005 (66.67%)	25
PRXProdigy Gold NL	AUD 0.003 (50.00%)	100.11k
ARVOCArtemis Resources Limited	AUD 0.003 (50.00%)	1.05M
MTBMount Burgess Mining Nl	AUD 0.0015 (50.00%)	5.38k
FRSOAForrestania Resources Ltd	AUD 0.006 (-57.14%)	26k
GGEOAGrand Gulf Energy Limited	AUD 0.001 (-50.00%)	2.18M
D2OOADuxton Water Limited	AUD 0.021 (-47.50%)	4.5k
IMUODImugene Ltd	AUD 0.001 (-33.33%)	2.54M
CT1Constellation Technologies Limited	AUD 0.002 (-33.33%)	50.02k
CCOCalmer Co International Ltd	AUD 0.007 (-12.50%)	37.06M
JRVJervois Global Ltd	AUD 0.023 (27.78%)	36.87M
BOTBotanix Pharmaceuticals Limited	AUD 0.3575 (6.72%)	36.13M
PLSPilbara Minerals Limited	AUD 3.085 (-3.44%)	25.5M
REDRed 5 Limited	AUD 0.4175 (3.09%)	22.64M